Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Emily Cole

Concepts (108)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tomography, Optical Coherence
17
2023
283
1.950
Why?
Fluorescein Angiography
12
2024
197
1.540
Why?
Retinal Vessels
10
2018
79
1.340
Why?
Diabetic Retinopathy
8
2018
211
1.120
Why?
Macular Degeneration
2
2023
196
1.070
Why?
Retinopathy of Prematurity
4
2023
183
1.040
Why?
Choroid
7
2016
81
0.970
Why?
Retinal Neoplasms
2
2024
47
0.960
Why?
Retinal Vasculitis
2
2024
12
0.960
Why?
Macular Edema
5
2018
49
0.950
Why?
Choroidal Neovascularization
4
2019
57
0.840
Why?
Retinal Diseases
2
2023
102
0.840
Why?
Myopia, Degenerative
1
2023
5
0.790
Why?
Vitreous Detachment
1
2023
6
0.790
Why?
Vitreous Body
1
2024
118
0.790
Why?
Rituximab
1
2024
208
0.770
Why?
Myopia
1
2023
59
0.750
Why?
Antineoplastic Agents, Immunological
1
2024
200
0.690
Why?
Laser Coagulation
3
2018
80
0.620
Why?
Telemedicine
3
2023
966
0.550
Why?
Diagnostic Imaging
2
2022
340
0.520
Why?
Fundus Oculi
7
2024
89
0.480
Why?
Diagnostic Techniques, Ophthalmological
1
2016
55
0.450
Why?
Retina
3
2023
330
0.360
Why?
Visual Acuity
3
2024
499
0.300
Why?
Intravitreal Injections
3
2024
73
0.260
Why?
Microcirculation
2
2017
142
0.240
Why?
Vascular Endothelial Growth Factor A
3
2016
545
0.220
Why?
Geographic Atrophy
2
2016
105
0.220
Why?
Reproducibility of Results
7
2022
3416
0.210
Why?
Capillaries
4
2018
123
0.200
Why?
Traction
1
2023
19
0.200
Why?
Macula Lutea
2
2018
21
0.170
Why?
Ophthalmology
1
2023
122
0.170
Why?
Angiogenesis Inhibitors
3
2016
239
0.160
Why?
Fovea Centralis
2
2019
24
0.160
Why?
Retinoblastoma
1
2021
53
0.160
Why?
Photography
1
2021
120
0.160
Why?
Diagnosis, Computer-Assisted
1
2021
92
0.150
Why?
Humans
24
2024
146342
0.150
Why?
Image Processing, Computer-Assisted
2
2021
778
0.140
Why?
Neonatal Screening
1
2020
185
0.140
Why?
Retinal Neovascularization
1
2018
29
0.140
Why?
Regional Blood Flow
2
2017
507
0.130
Why?
Infant, Newborn
4
2023
6460
0.130
Why?
Retinitis
1
2017
21
0.130
Why?
Retinal Artery Occlusion
1
2017
10
0.130
Why?
Cross-Sectional Studies
6
2023
5899
0.130
Why?
Retrospective Studies
7
2023
17438
0.130
Why?
Optic Neuropathy, Ischemic
1
2017
31
0.130
Why?
Follow-Up Studies
5
2020
5439
0.130
Why?
Aneurysm
1
2017
37
0.130
Why?
Visual Fields
1
2017
120
0.130
Why?
Optic Disk
1
2017
57
0.130
Why?
Optic Disk Drusen
1
2016
6
0.120
Why?
Choroid Diseases
1
2016
10
0.120
Why?
Ranibizumab
1
2016
21
0.120
Why?
Retinal Drusen
1
2016
31
0.120
Why?
Retinal Pigment Epithelium
1
2016
81
0.110
Why?
Internet
1
2020
660
0.110
Why?
Bevacizumab
1
2016
169
0.110
Why?
Ischemia
1
2018
421
0.110
Why?
Wet Macular Degeneration
1
2016
63
0.110
Why?
Gestational Age
3
2023
990
0.100
Why?
Male
15
2023
73396
0.090
Why?
Clinical Trials as Topic
1
2016
1064
0.080
Why?
Cohort Studies
1
2022
6077
0.080
Why?
Aged
8
2019
26432
0.080
Why?
Female
14
2023
79499
0.080
Why?
Prospective Studies
5
2023
8123
0.080
Why?
Time Factors
2
2016
7109
0.070
Why?
Aged, 80 and over
5
2019
8391
0.070
Why?
Sensitivity and Specificity
2
2023
1998
0.060
Why?
Middle Aged
9
2019
36619
0.060
Why?
Artifacts
2
2016
143
0.060
Why?
Computed Tomography Angiography
2
2016
151
0.060
Why?
Ethers, Cyclic
1
2023
11
0.050
Why?
Ophthalmoscopy
1
2023
38
0.050
Why?
Benzofurans
1
2023
26
0.050
Why?
Smartphone
1
2023
103
0.040
Why?
Nepal
1
2021
31
0.040
Why?
Mongolia
1
2020
6
0.040
Why?
Datasets as Topic
1
2021
120
0.040
Why?
Reference Standards
1
2021
176
0.040
Why?
Area Under Curve
1
2021
335
0.040
Why?
North America
1
2021
300
0.040
Why?
ROC Curve
1
2021
617
0.040
Why?
Observer Variation
1
2019
356
0.030
Why?
Developing Countries
1
2021
312
0.030
Why?
Infant, Premature
1
2023
622
0.030
Why?
Artificial Intelligence
1
2023
389
0.030
Why?
Birth Weight
1
2021
521
0.030
Why?
Doppler Effect
1
2017
2
0.030
Why?
Vitrectomy
1
2017
74
0.030
Why?
Microaneurysm
1
2016
1
0.030
Why?
Adult
4
2023
41087
0.030
Why?
Multimodal Imaging
1
2016
137
0.030
Why?
Blood Flow Velocity
1
2016
419
0.030
Why?
Incidence
1
2020
2936
0.020
Why?
Analysis of Variance
1
2016
1298
0.020
Why?
Health Services Accessibility
1
2021
1107
0.020
Why?
Case-Control Studies
1
2016
3647
0.020
Why?
Severity of Illness Index
1
2017
2921
0.020
Why?
Infant
1
2023
10114
0.020
Why?
Algorithms
1
2016
1849
0.020
Why?
Risk Factors
1
2020
10921
0.010
Why?
Diabetes Mellitus, Type 2
1
2018
2623
0.010
Why?
Treatment Outcome
1
2016
11821
0.010
Why?
Cole's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)